UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 246.60
-5.40 (-2.14%)
At close: Mar 20, 2026
UCB SA Market Cap
UCB SA has a market cap or net worth of €46.94 billion as of March 20, 2026. Its market cap has increased by 36.47% in one year.
Market Cap
46.94B
Enterprise Value
46.83B
Revenue
7.74B
Ranking
n/a
PE Ratio
30.71
Stock Price
€246.60
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 46.94B, an increase of 5,170.56%. That is a compound annual growth rate of 13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 46.94B | 3.55% |
| Dec 31, 2025 | 45.33B | 24.32% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 36.29B |
| Financière de Tubize | 9.08B |
| Onward Medical | 193.79M |
| Hyloris Pharmaceuticals | 157.36M |
| European Medical Solutions | 21.16M |
| Celyad Oncology | 14.77M |
| BioSenic | 1.57M |
| Oxurion NV | 392.55K |